According to our (Global Info Research) latest study, the global Myopia Control Management in Children and Teenagers market size was valued at US$ 1915 million in 2025 and is forecast to a readjusted size of US$ 5023 million by 2032 with a CAGR of 14.3% during review period.
Myopia control aims to slow down the progression or worsening of myopia in children and teenagers, so that their final amount of myopia is less than what it would have been without treatment.
Myopia control is important to both improve your child or teenagers' vision with less frequent changes in prescription in childhood, as well as reducing their lifelong risk of eye diseases and vision impairment associated with higher levels of myopia.
Myopia control treatments include special types of spectacle lenses, soft contact lenses, ortho-k and atropine eye drops.
Myopia Control Management in Children and Teenagers is a specialized eye health product market focused on interventions to slow myopia progression in children and teenagers. Its core objective is not simply to correct vision, but to delay the progression of myopia and axial elongation through specific optical designs, corneal reshaping, contact lens defocus designs, or low-dose pharmaceutical intervention. The scope of this study covers only four product categories: myopia control spectacle lenses, orthokeratology lenses, multifocal or defocus-designed soft contact lenses, and low-dose atropine eye drops.
Among these products, myopia control spectacle lenses are currently the most widely adopted category, with relatively low usage barriers. These lenses use multi-zone defocus, micro-lens arrays, peripheral defocus, or special optical zone designs to provide clear vision correction while generating myopic defocus signals on the retina, thereby helping to slow myopia progression. They are suitable for most children and teenagers in daily study, outdoor activities, and long-term wearing scenarios. Representative products include HOYA MiYOSMART, ZEISS MyoCare/MyoVision, and Essilor Stellest.
Orthokeratology lenses are another important product category for myopia control. They are typically worn overnight to temporarily reshape the anterior corneal surface, allowing children to achieve relatively clear unaided vision during the day while also creating a certain peripheral defocus effect to control myopia progression. These products have relatively high unit prices and require professional fitting expertise, regular follow-up, strong care compliance, and suitable corneal conditions. They are mainly used in hospital ophthalmology departments, professional optometry centers, and high-end vision care institutions.
Multifocal or defocus-designed soft contact lenses mainly include daily disposable, monthly disposable, and customized soft contact lens products. Through multifocal, concentric-ring, EDOF, or other defocus designs, these lenses provide daytime vision correction while supporting myopia management. This product category has gained certain adoption in markets such as Europe, the United States, Japan, and Australia. Representative products include CooperVision MiSight 1 day, Johnson & Johnson Abiliti 1-Day, SEED 1dayPure EDOF, and Mark’ennovy MYLO. However, approved indications, sales channels, and prescribing habits vary across different countries and regions.
Low-dose atropine eye drops are a pharmaceutical intervention product for myopia control. They are mainly used through long-term administration of low-dose atropine to slow myopia progression in children and teenagers. These products usually require a doctor’s prescription and rely on regular follow-up and medication compliance management. Around 2025, commercialized or approved products gradually emerged in markets such as China, Japan, Australia, India, and Europe. Representative companies include Xingqi Ophthalmic Medicine, Santen, Aspen, and ENTOD Pharmaceuticals. Compared with spectacle lenses and orthokeratology lenses, low-dose atropine eye drops are still in the early stage of market introduction, with relatively low penetration. However, with the increase in approved products, the improvement of concentration gradients, and rising acceptance among doctors, this category still has certain growth potential.
This report is a detailed and comprehensive analysis for global Myopia Control Management in Children and Teenagers market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Myopia Control Management in Children and Teenagers market size and forecasts, in consumption value ($ Million), 2021-2032
Global Myopia Control Management in Children and Teenagers market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Myopia Control Management in Children and Teenagers market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Myopia Control Management in Children and Teenagers market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Myopia Control Management in Children and Teenagers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Myopia Control Management in Children and Teenagers market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include HOYA Corporation, ZEISS, CooperVision, EssilorLuxottica, Ovctek, Alpha Corporation, EUCLID, Brighten Optix, Lucid Korea, WeiXing Optical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Myopia Control Management in Children and Teenagers market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Spectacles for Myopia Control
Soft Contact Lenses for Myopia Control
Ortho-k Contact Lenses
Atropine Eye Drops
Market segment by Sales Channel
Eye Hospital
Eye Clinic
Brand Store
Eyewear Retail Store
Online Sales
Market segment by Usage Scenario
Daily Learning
Near-work/Screen Use
Outdoor Activities
Nighttime Intervention
Market segment by Application
Children
Teenagers
Market segment by players, this report covers
HOYA Corporation
ZEISS
CooperVision
EssilorLuxottica
Ovctek
Alpha Corporation
EUCLID
Brighten Optix
Lucid Korea
WeiXing Optical
Contex
Jiangsu Green Stone Optical (SETO)
Conant
Johnson & Johnson
Visioneering Technologies
Mark'ennovy
SEED
Aspen
ENTOD Pharmaceuticals
Santen Pharmaceutical
Shenyang Xingqi Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Myopia Control Management in Children and Teenagers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Myopia Control Management in Children and Teenagers, with revenue, gross margin, and global market share of Myopia Control Management in Children and Teenagers from 2021 to 2026.
Chapter 3, the Myopia Control Management in Children and Teenagers competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Myopia Control Management in Children and Teenagers market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Myopia Control Management in Children and Teenagers.
Chapter 13, to describe Myopia Control Management in Children and Teenagers research findings and conclusion.
Summary:
Get latest Market Research Reports on Myopia Control Management in Children and Teenagers. Industry analysis & Market Report on Myopia Control Management in Children and Teenagers is a syndicated market report, published as Global Myopia Control Management in Children and Teenagers Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Myopia Control Management in Children and Teenagers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.